在接受宫支臂治疗的妇女中,比较了三种止痛疗法
Nicholas Chee1, Alyson McGrath2, Stephen R Thompson3
1Department of Anaesthesia, Royal Hospital for Women, Randwick, NSW, Australia; Nepean Hospital, Kingswood, NSW, Australia.
Brachytherapy
|July 9, 2023
概括
与患者控制的外周止痛疗法 (PIEB-PCEA) 进行编程间歇性外周止痛,为宫支臂治疗患者提供了优越的疼痛控制. 这种方法比静脉注射患者控制止痛药 (IV-PCA) 或连续外周输液 (CEI) 更安全,更有效.
科学领域:
- 在瘤学瘤学.
- 麻醉学 麻醉学
- 疼痛管理 疼痛管理
背景情况:
- 有效的疼痛管理对于在宫支臂治疗期间的患者舒适性至关重要.
- 存在不同的止痛方式,包括静脉注射患者控制止痛 (IV-PCA),连续外周输注 (CEI) 和患者控制外周止痛 (PIEB-PCEA) 的编程间歇性外周玻尿酸.
研究的目的:
- 为了比较IV-PCA,CEI和PIEB-PCEA的疗效和安全性,用于宫支臂治疗中的周围手术止痛.
- 评估不同疼痛管理策略的疼痛评分和止痛药消耗.
主要方法:
- 对36名患者的97次支臂疗法发作进行了回顾性审查.
- 在两个阶段进行疼痛评分的分析:应用器在现场 (第一阶段) 和应用器后移除 (第二阶段).
- 在止痛剂组中比较中位疼痛得分,不可接受的疼痛经历和口服吗啡总相当剂量 (OMED).
主要成果:
- 在第一阶段,PIEB-PCEA和CEI显示,与IV-PCA相比,疼痛中位数得分明显较低,不可接受的疼痛发作较少.
- 在第二阶段,IV-PCA和PIEB-PCEA表现出比CEI更好的疼痛控制.
- 与IV-PCA (70 mg) 和CEI (15 mg) 相比,PIEB-PCEA组使用的阿片类药物显著减少 (OMED中位数为0 mg).
结论:
- 编程间歇性外围注射与患者控制的外围注射止痛 (PIEB-PCEA) 为宫支臂疗法提供了优越的止痛.
- PIEB-PCEA是一种安全有效的替代方案,用于管理应用器放置后的疼痛,其性能优于IV-PCA和CEI.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
346
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
346
Analgesia and Pain Management
665
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
665
Local Anesthetics: Clinical Application as Epidural Anesthesia
458
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
458
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
205
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
205
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
249
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
249
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
324
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
324


